These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31436505)

  • 21. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
    Luo J
    Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Implications of CRISPR-Cas9 Genome Editing for IR.
    Perkons NR; Sheth R; Ackerman D; Chen J; Saleh K; Hunt SJ; Nadolski GJ; Shi J; Gade TP
    J Vasc Interv Radiol; 2018 Sep; 29(9):1264-1267.e1. PubMed ID: 30146193
    [No Abstract]   [Full Text] [Related]  

  • 24. The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.
    Bayat H; Omidi M; Rajabibazl M; Sabri S; Rahimpour A
    J Microbiol Biotechnol; 2017 Feb; 27(2):207-218. PubMed ID: 27840399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Special Issue on the Chemical Biology of CRISPR.
    Weidmann AG; Choudhary A
    ACS Chem Biol; 2018 Feb; 13(2):283-284. PubMed ID: 29448763
    [No Abstract]   [Full Text] [Related]  

  • 26. Human germline editing: a historical perspective.
    Morange M
    Hist Philos Life Sci; 2017 Oct; 39(4):34. PubMed ID: 29038945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of CRISPR in evolution analysis, detecting and typing, virulence and antibiotic resistance regulation in food-borne pathogens].
    Bai Z; Wang W; Ji X; Xiao Y; Zhang S; Wang Z; Li H; Dong Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Jul; 37(7):2414-2424. PubMed ID: 34327906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Panacea in progress: CRISPR and the future of its biological research introduction.
    Carroll M; Zhou X
    Microbiol Res; 2017 Aug; 201():63-74. PubMed ID: 28602403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Accelerated Gene Drives Pump the Brakes.
    LeMieux J
    CRISPR J; 2019 Aug; 2():196-198. PubMed ID: 31436503
    [No Abstract]   [Full Text] [Related]  

  • 33. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Base Editing Systems Are Available for Plants.
    Marzec M; Hensel G
    Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research progress and applications of gene editing technology CRISPR/Cas in zebrafish].
    Ouyang J; Xue S; Zhou Q; Cui H
    Sheng Wu Gong Cheng Xue Bao; 2020 Jan; 36(1):1-12. PubMed ID: 32072776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitizing pathogens to antibiotics using the CRISPR-Cas system.
    Goren M; Yosef I; Qimron U
    Drug Resist Updat; 2017 Jan; 30():1-6. PubMed ID: 28363331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome editing: CRISPR-Cas becoming more human.
    Baumann K
    Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
    [No Abstract]   [Full Text] [Related]  

  • 40. CRISPR-Cas in its prime.
    Zlotorynski E
    Nat Rev Mol Cell Biol; 2019 Dec; 20(12):718-719. PubMed ID: 31685954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.